When and how to treat essential thrombocythemia
- PMID: 16000360
- DOI: 10.1056/NEJMe058093
When and how to treat essential thrombocythemia
Comment on
-
Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.N Engl J Med. 2005 Jul 7;353(1):33-45. doi: 10.1056/NEJMoa043800. N Engl J Med. 2005. PMID: 16000354 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical